5-Fluorouracil related encephalopathy: at least two distinct pathogenetic mechanisms exist - reply

被引:3
作者
Yeh, KH
Cheng, AL
机构
[1] Natl Taiwan Univ Hosp, Dept Oncol, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 100, Taiwan
[4] Natl Taiwan Univ, Coll Med, Ctr Canc Res, Taipei 100, Taiwan
关键词
D O I
10.1038/bjc.1998.283
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1711 / 1712
页数:2
相关论文
共 50 条
[41]   SYSTEMIC-SCLEROSIS POSSIBLY CAUSED BY 5-FLUOROURACIL - REPLY [J].
MARINO, C ;
MCDONALD, E ;
ALUNDAY, A .
NEW YORK STATE JOURNAL OF MEDICINE, 1991, 91 (01) :35-35
[42]   ADJUVANT TREATMENT WITH 5-FLUOROURACIL FOR COLORECTAL-CANCER - REPLY [J].
FIELDING, LP ;
HITTINGER, R ;
GRACE, RH ;
FRY, JS .
LANCET, 1992, 340 (8831) :1349-1350
[43]   Two cases of coronary vasospasm induced by 5-fluorouracil [J].
Atar, Asli ;
Korkmaz, Mehmet Emin ;
Ozin, Bulent .
ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2010, 10 (05) :461-462
[44]   ON MECHANISMS OF SYNERGY OF 5-FLUOROURACIL DEOXYRIBOSIDE (FUDR) AND IONIZING RADIATIONS [J].
MOUTSCHEN, J ;
JANA, MK ;
DEGRAEVE, N .
CARYOLOGIA, 1966, 19 (04) :531-+
[45]   Synergistic Mechanisms of 5-Fluorouracil and Imiquimod in the Treatment of Actinic Keratoses [J].
Regester, R. Maxwell ;
Cannella, Amy C. ;
Thiele, Geoffrey M. ;
Griess, Anthony J. .
JOURNAL OF DRUGS IN DERMATOLOGY, 2025, 24 (05) :e35-e35
[46]   STUDIES ON MECHANISMS OF 5-FLUOROURACIL RESISTANCE IN MURINE AND HUMAN TUMORS [J].
ARDALAN, B ;
MACDONALD, JS ;
COONEY, D ;
SCHEIN, PS .
BULLETIN DU CANCER, 1979, 66 (01) :55-59
[47]   5-FLUOROURACIL ENCEPHALOPATHY FULFILLING STROKE CRITERIA FOR TISSUE PLASMINOGEN ACTIVATOR THERAPY [J].
Nguyen, May ;
Stoianovici, Robyn ;
Cheng, Serena ;
Chari, Venai ;
Chukwuneke, Florence ;
Weber, Rebecca ;
Brunetti, Luigi .
CRITICAL CARE MEDICINE, 2016, 44 (12)
[48]   SCHEDULE-DEPENDENT RESISTANCE MECHANISMS VS 5-FLUOROURACIL [J].
HARSTRICK, A .
ONKOLOGIE, 1995, 18 (01) :95-96
[49]   Cytotoxic effects and mechanisms of an alteration in the dose and duration of 5-fluorouracil [J].
Patel, M ;
Ardalan, K ;
Hochman, I ;
Tian, EM ;
Ardalan, B .
ANTICANCER RESEARCH, 2003, 23 (1A) :447-452
[50]   Posterior Reversible Encephalopathy Syndrome (PRES) After Treatment With Oxaliplatin and 5-Fluorouracil [J].
Truman, Nicholas ;
Nethercott, Daniel .
CLINICAL COLORECTAL CANCER, 2013, 12 (01) :70-72